Study type: Human research · Status: Verified against declared source
Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation.
PubMed · 2018
Study scale: Patient records from January to December 2015 were screened for patients eligible for this study according to the inclusion and exclusion criteria.
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Aim: This study assessed the efficacy of Cerebrolysin on post-stroke spasticity, motor recovery, and global functions in an outpatient rehabilitation setting.
Methods
Aim: This study assessed the efficacy of Cerebrolysin on post-stroke spasticity, motor recovery, and global functions in an outpatient rehabilitation setting.
Scale or participants
Patient records from January to December 2015 were screened for patients eligible for this study according to the inclusion and exclusion criteria.
Key findings
Results: A total of 50 patients were eligible for participation according to the inclusion and exclusion criteria.
Limitations and uncertainty
Conclusion: Cerebrolysin had a beneficial effect on post-stroke spasticity in an outpatient rehabilitation setting; intramuscular treatment for over 30 days was safe and well tolerated.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.